Kanabo Group (GB:KNB) has released an update.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Kanabo Group, an innovator in digital health and specialized medicines, reported a significant 55% revenue increase in the first half of 2024, driven by the expansion of their Treat-It clinic franchise and advancements in AI and e-prescription technologies. The company, which focuses on telehealth platforms and cannabis-based treatments, is poised for further growth with confidence in their strategic plan and upcoming product launches. Amidst these developments, Kanabo remains committed to enhancing patient access to healthcare and operational efficiency.
For further insights into GB:KNB stock, check out TipRanks’ Stock Analysis page.